[go: up one dir, main page]

NO20014379L - Anvendelse av Xenon for behandling av Neurointoksikasjoner - Google Patents

Anvendelse av Xenon for behandling av Neurointoksikasjoner

Info

Publication number
NO20014379L
NO20014379L NO20014379A NO20014379A NO20014379L NO 20014379 L NO20014379 L NO 20014379L NO 20014379 A NO20014379 A NO 20014379A NO 20014379 A NO20014379 A NO 20014379A NO 20014379 L NO20014379 L NO 20014379L
Authority
NO
Norway
Prior art keywords
neurointoxics
xenon
treatment
Prior art date
Application number
NO20014379A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014379D0 (no
Inventor
Christian Petzelt
Wolfgang J Kox
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7900688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20014379(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aga Ab filed Critical Aga Ab
Publication of NO20014379D0 publication Critical patent/NO20014379D0/no
Publication of NO20014379L publication Critical patent/NO20014379L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20014379A 1999-03-11 2001-09-10 Anvendelse av Xenon for behandling av Neurointoksikasjoner NO20014379L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19910986A DE19910986C2 (de) 1999-03-11 1999-03-11 Verwendung von Xenon bei der Behandlung von Neurointoxikationen
PCT/EP2000/002025 WO2000053192A1 (fr) 1999-03-11 2000-03-08 Utilisation de xenon pour traiter les neurointoxications

Publications (2)

Publication Number Publication Date
NO20014379D0 NO20014379D0 (no) 2001-09-10
NO20014379L true NO20014379L (no) 2001-11-07

Family

ID=7900688

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014379A NO20014379L (no) 1999-03-11 2001-09-10 Anvendelse av Xenon for behandling av Neurointoksikasjoner

Country Status (29)

Country Link
US (3) US6559190B1 (fr)
EP (1) EP1158992B2 (fr)
JP (1) JP4954373B2 (fr)
KR (1) KR100674407B1 (fr)
CN (1) CN1170544C (fr)
AR (1) AR022886A1 (fr)
AT (1) ATE248599T1 (fr)
AU (1) AU757361B2 (fr)
BG (1) BG105889A (fr)
BR (1) BR0010456A (fr)
CA (1) CA2367136C (fr)
CZ (1) CZ302864B6 (fr)
DE (2) DE19910986C2 (fr)
DK (1) DK1158992T3 (fr)
EE (1) EE200100480A (fr)
ES (1) ES2206202T5 (fr)
HK (1) HK1048073B (fr)
HU (1) HUP0201393A3 (fr)
IL (2) IL145177A0 (fr)
MD (1) MD2935C2 (fr)
NO (1) NO20014379L (fr)
PL (1) PL202941B1 (fr)
PT (1) PT1158992E (fr)
RS (1) RS49756B (fr)
RU (1) RU2246949C2 (fr)
SI (1) SI1158992T1 (fr)
SK (1) SK285111B6 (fr)
WO (1) WO2000053192A1 (fr)
ZA (1) ZA200107291B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913677D0 (en) 1999-06-11 1999-08-11 Imperial College Formulation
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
US6653354B2 (en) 1999-07-29 2003-11-25 Protexeon Limited NMDA antagonist comprising xenon
DE10045829A1 (de) * 2000-09-14 2002-04-04 Messer Griesheim Gmbh Volatile Anästhesiemittel mit Xenon
DE10054563A1 (de) * 2000-11-03 2002-05-16 Messer Griesheim Gmbh Verfahren und Vorrichtung zur Betonherstellung
US20020102211A1 (en) * 2000-12-07 2002-08-01 Renshaw Perry F. Use of magnetic resonance imaging in diagnosis of membrane fluidity-related disorders
GB0210021D0 (en) * 2002-05-01 2002-06-12 Air Prod & Chem Ultrasonic gas analyser
GB0209998D0 (en) † 2002-05-01 2002-06-12 Protexeon Ltd Use
EP1515732B1 (fr) * 2002-06-12 2009-01-14 Air Liquide Deutschland GmbH Protection cerebrale a l'aide d'un gaz contenant du xenon
WO2004004782A1 (fr) * 2002-07-05 2004-01-15 Messer Griesheim Gmbh Adjuvant contenant du xenon
GB0218153D0 (en) * 2002-08-05 2002-09-11 Ic Innovations Ltd An analgesic agent for newborn or retal subjects
US7337776B2 (en) 2002-08-20 2008-03-04 Aga Ab Methods for easing pain and anxiety from atrial or ventricular defibrillation
US7681572B2 (en) 2002-08-20 2010-03-23 Aga Ab Method and devices for administration of therapeutic gases
FR2858233B1 (fr) * 2003-07-30 2008-04-11 Air Liquide Sante Int Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
ES2298815T3 (es) * 2003-10-10 2008-05-16 Protexeon Limited Uso de xenon con hipotermia para tratar asfixia neonatal.
CA2542412A1 (fr) * 2003-10-21 2005-05-06 Aga Ab Emploi du xenon pour contrer la mort programmee des cellules
FR2863169B1 (fr) 2003-12-08 2006-02-10 Air Liquide Sante Int Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications
EP1552840A1 (fr) * 2004-01-07 2005-07-13 Aga Ab Mélange de xénon et de monoxyde de carbone pour la protection de cellules
US7070005B2 (en) * 2004-02-10 2006-07-04 Planetair Turf Products, Llc Soil aerator assembly
ATE553757T1 (de) * 2004-08-02 2012-05-15 John W Olney Verhinderung von pathologischen anstiegen der nervenzellsuizidrate in unreifen nervensystemen
WO2007075100A1 (fr) * 2005-12-27 2007-07-05 Zakrytoe Aktsionernoe Obshchestvo 'atom-Med Center' Procédé de traitement de la toxicomanie
EP1980260A1 (fr) * 2007-04-10 2008-10-15 Nicholas Peter Franks Utilisation de conditions hyperbares pour fournir une neuroprotection
CA2685446A1 (fr) 2007-04-30 2008-11-06 Nnoxe Pharmaceutiques Inc. Composition pharmaceutique comprenant au moins un agent thrombolytique (a) et au moins un gaz (b) choisi dans le groupe compose d'axyde nitrique, d'argon, de xenon, d'helium, de neon
ITMI20071031A1 (it) * 2007-05-22 2008-11-23 Acetilene & Deriv Ati Siad Spa Uso di xenon per la protezione di organi da danno ischemico
WO2010035074A1 (fr) * 2008-09-25 2010-04-01 Nnoxe Pharmaceutiques Inc Utilisation d'oxyde de diazote, d'argon, de xénon, d'hélium ou de néon pour fabriquer une composition pharmaceutique destinée à traiter des lésions ischémiques chez des patients ne pouvant pas être traités par des agents thrombolytiques
FR2952305B1 (fr) 2009-11-10 2012-04-27 Air Liquide Medicament inhalable a base de xenon pour traiter ou pour prevenir les dyskinesies
WO2011081612A1 (fr) * 2009-12-31 2011-07-07 Bondarenko Vitaliy Leonidovich Utilisation de krypton ou de xénon comme agent antiviral
FR2956323B1 (fr) 2010-02-15 2013-12-20 Air Liquide Medicament gazeux inhalable a base d'argon contre les deficiences ou defaillances d'organes peripheriques
FR2960779A1 (fr) 2010-06-08 2011-12-09 Air Liquide Medicament gazeux inhalable a base de krypton contre les deficiences ou defaillances d'organes peripheriques
FR2964036B1 (fr) 2010-08-24 2013-04-12 Air Liquide Medicament gazeux inhalable a base de krypton pour le traitement des neuro-intoxications
WO2012109107A1 (fr) 2011-02-07 2012-08-16 Rich Products Corporation Procédé de préservation de cellules et de cultures cellulaires
FR2975597B1 (fr) * 2011-05-24 2013-12-27 Air Liquide Utilisation de neon pour le traitement des neuro-intoxications, notamment des maladies enurodegeneratives et demyelinisantes
PT2760991T (pt) 2011-09-26 2018-02-05 Rich Tech Holding Company Llc Método para a conservação de tecido vivo
RU2489154C1 (ru) * 2012-05-31 2013-08-10 Сергей Александрович Наумов Способ лечения вирусных гепатитов
CN103565745A (zh) 2012-08-10 2014-02-12 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
FR2996458B1 (fr) * 2012-10-09 2015-02-27 Air Liquide Utilisation de xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996459B1 (fr) * 2012-10-09 2015-02-06 Air Liquide Utilisation d'un melange argon/xenon pour prevenir ou traiter les consequences neurologiques d'un choc septique
FR2996457B1 (fr) 2012-10-09 2019-11-29 L'air Liquide,Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Utilisation d'argon pour prevenir ou traiter les consequences neurologiques d'un choc septique
PT2931291T (pt) 2012-12-11 2021-12-03 Mclean Hospital Corp Tratamento com xénon como complemento da psicoterapia para perturbações psiquiátricas
WO2014145443A2 (fr) 2013-03-15 2014-09-18 The Board Of Regents Of The University Of Texas System Liquides riches en gaz noble et leurs procédés de préparation et d'utilisation
FR3007983B1 (fr) * 2013-07-08 2015-06-26 Air Liquide Association de xenon et d'un antagoniste des recepteurs nmda pour lutter contre une maladie neurodegenerative
FR3022456B1 (fr) * 2014-06-20 2016-07-15 Air Liquide Xenon associe a un antagoniste des recepteurs nmda pour lutter contre une proliferation tumorale dans le systeme nerveux central
FR3027226B1 (fr) * 2014-10-17 2017-12-08 L'air Liquide Sa Pour L'etude Et L'exploitation Des Procedes Georges Claude Medicament pour traiter une maladie liee a un dysfonctionnement de la transmission synaptique dopaminergique
JP6622822B2 (ja) * 2015-06-23 2019-12-18 ノビリス セラピューティクス インコーポレイテッド 希ガス組成物を用いた治療的な免疫調節
CN108367024A (zh) * 2015-11-09 2018-08-03 麦克莱恩医院 用于预防自杀、杀人和自伤行为的方法及组合物
US20170341980A1 (en) * 2016-05-31 2017-11-30 Noblis Therapeutics, Inc. Noble gas neuroprotection and neuroregeneration from treatment related neurotoxicity
US10485825B2 (en) * 2016-08-29 2019-11-26 Nobilis Therapeutics, Inc. Prevention of pregnancy complications by noble gas administration
EP3532073A4 (fr) * 2016-10-31 2020-09-02 Nobilis Therapeutics, Inc. Traitement de trouble de l'anxiété et augmentation des interventions anti-anxiété par administration de mélanges contenant un gaz noble
CN107569509B (zh) * 2017-02-22 2018-09-21 滨州医学院 氙或氙气体混合物在制备治疗癫痫的制剂中的用途
CN108986622A (zh) * 2018-08-16 2018-12-11 广州迈普再生医学科技股份有限公司 一种颅内血肿微创穿刺清除术培训装置及其制备方法
RU2712804C1 (ru) * 2018-08-29 2020-01-31 Жовнерчук Инна Юрьевна Способ коррекции функционального состояния человека в замкнутом пространстве
RU2789964C1 (ru) * 2022-04-01 2023-02-14 Александр Юрьевич Верховский Способ улучшения состояния кожи и подкожных тканей

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5099834A (en) * 1991-07-16 1992-03-31 Union Carbide Industrial Gases Technology Corporation Method for anesthesia
US5228434A (en) * 1991-07-16 1993-07-20 Praxair Technology, Inc. Mixture for anesthesia
US5357959A (en) * 1993-04-16 1994-10-25 Praxair Technology, Inc. Altered dipole moment magnetic resonance imaging method
RU2145606C1 (ru) * 1994-05-24 2000-02-20 Ф.Хоффманн-Ля Рош Аг Трициклические дикарбонильные производные и лекарственный препарат на их основе
RU2072241C1 (ru) * 1995-09-20 1997-01-27 Панина Елена Владимировна Способ формирования дыхательной газовой смеси и аппарат для его осуществления
US5846556A (en) * 1996-06-14 1998-12-08 Brooks; Bradley S. Inhalant for reducing stress and method of use
IT1286058B1 (it) * 1996-10-29 1998-07-07 Siad Societa Italiana Acetilen Procedimento e apparecchiatura per la purificazione e recupero dello xeno e altri gas nobili in sistemi anestetici
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
DE19823606C2 (de) * 1998-05-27 2002-02-28 Draeger Medical Ag Verwendung von Perfluorcarbone in einem Atemgasgemisch sowie die Vorrichtung
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist

Also Published As

Publication number Publication date
PT1158992E (pt) 2004-01-30
BG105889A (bg) 2002-04-30
DE19910986A1 (de) 2000-09-21
YU65401A (sh) 2004-07-15
HUP0201393A2 (en) 2002-09-28
HUP0201393A3 (en) 2002-10-28
IL145177A0 (en) 2002-06-30
MD2935B2 (en) 2005-12-31
CN1359296A (zh) 2002-07-17
US8143317B2 (en) 2012-03-27
US20030180375A1 (en) 2003-09-25
ZA200107291B (en) 2003-02-26
EE200100480A (et) 2002-12-16
SI1158992T1 (en) 2004-02-29
CA2367136A1 (fr) 2000-09-14
ATE248599T1 (de) 2003-09-15
AU757361B2 (en) 2003-02-20
CN1170544C (zh) 2004-10-13
BR0010456A (pt) 2002-08-27
AU3287500A (en) 2000-09-28
JP2002538209A (ja) 2002-11-12
HK1048073A1 (en) 2003-03-21
AR022886A1 (es) 2002-09-04
US20070110821A1 (en) 2007-05-17
PL350618A1 (en) 2003-01-27
PL202941B1 (pl) 2009-08-31
EP1158992B2 (fr) 2012-02-01
SK12792001A3 (sk) 2002-07-02
SK285111B6 (sk) 2006-06-01
KR20010108338A (ko) 2001-12-07
ES2206202T5 (es) 2012-05-22
EP1158992A1 (fr) 2001-12-05
DE60004974T3 (de) 2012-06-28
WO2000053192A1 (fr) 2000-09-14
HK1048073B (zh) 2005-06-03
IL145177A (en) 2006-10-31
EP1158992B1 (fr) 2003-09-03
DE19910986C2 (de) 2001-06-07
DK1158992T3 (da) 2003-12-29
ES2206202T3 (es) 2004-05-16
DE60004974D1 (de) 2003-10-09
CA2367136C (fr) 2008-05-13
US6559190B1 (en) 2003-05-06
MD20010349A (en) 2002-02-28
KR100674407B1 (ko) 2007-01-26
MD2935C2 (ro) 2006-08-31
JP4954373B2 (ja) 2012-06-13
RS49756B (sr) 2008-04-04
CZ20013234A3 (cs) 2002-06-12
DE60004974T2 (de) 2004-07-22
NO20014379D0 (no) 2001-09-10
RU2246949C2 (ru) 2005-02-27
CZ302864B6 (cs) 2011-12-21

Similar Documents

Publication Publication Date Title
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20013380L (no) 2-aminobenzoksazinonderivater for behandling av fedme
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
FI20000863A0 (fi) Uusi hoitomenetelmä
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
DK1176964T3 (da) Brug af ET743 til behandling af cancer
NO20015288D0 (no) Anvendelse av makrolide forbindelser for behandling av tört öye
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20020784L (no) Medikament for behandling av brudd
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
FI4299U1 (fi) Saunasuodatin
NO20013725D0 (no) Anvendelsen av antikonvulsive derivater for behandling av bulimi nervosa
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20014476D0 (no) Behandling av hiatial hernia
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
SE9903421D0 (sv) Behandlingsförfarande
NO996166L (no) FremgangsmÕte for behandling av avluter
NO20014092L (no) Behandling av infertilitet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application